Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SoftMedX HealthcareCCWYF 54 3-1 Month Momentum % is N/A% as of Aug. 25, 2026. GuruFocus rates CCWYF with a GF Score™ of 54/100 and a GF Value™ of $2.99. The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, SoftMedX Healthcare ranks worse than 99.55% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-25), SoftMedX Healthcare's 3-1 Month Momentum % is N/A%.
The industry rank for SoftMedX Healthcare's 3-1 Month Momentum % or its related term are showing as below:
CCWYF's 3-1 Month Momentum % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: -2.08 * Ranked among companies with meaningful 3-1 Month Momentum % only.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
SoftMedX Healthcare 3-1 Month Momentum % Related Terms
CCWYF vs HCA, THC, DVA: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, SoftMedX Healthcare's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SoftMedX Healthcare 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SoftMedX Healthcare's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where SoftMedX Healthcare's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SoftMedX Healthcare (CCWYF) has a 3-1 Month Momentum % of N/A% as of Aug. 25, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on SoftMedX Healthcare and its competitors. According to the industry distribution chart, SoftMedX Healthcare ranks #662 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 99.5%.
Is SoftMedX Healthcare's 3-1 Month Momentum % too high?
SoftMedX Healthcare's current 3-1 Month Momentum % is N/A%. Based on the distribution chart, SoftMedX Healthcare ranks #662 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, SoftMedX Healthcare has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does SoftMedX Healthcare's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, SoftMedX Healthcare ranks #662 out of 665 companies for 3-1 Month Momentum %. This places SoftMedX Healthcare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on SoftMedX Healthcare and its competitors. SoftMedX Healthcare's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftMedX Healthcare stock overvalued right now?
SoftMedX Healthcare (CCWYF) has a current 3-1 Month Momentum % of N/A%. The stock's GF Value™ is $2.99, compared to a current price of $0.70 — trading 76.6% below its estimated fair value. The current 3-1 Month Momentum % is N/A%. SoftMedX Healthcare's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For SoftMedX Healthcare (CCWYF), the current 3-1 Month Momentum % is N/A% as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SoftMedX Healthcare (CCWYF) Overvalued in 2026?
Based on GuruFocus' analysis, SoftMedX Healthcare stock appears to be undervalued.
The current stock price of $0.70 is trading 76.6% below its estimated GF Value™ of $2.99.
Key valuation signals for CCWYF:
3-1 Month Momentum %: N/A%
GF Value™: $2.99 vs. price of $0.70 (76.6% below fair value)
No single metric tells the full story. See the CCWYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SoftMedX Healthcare Ltd is principally engaged in the distribution of medical and healthcare equipment and products. The Group has one reportable operating segment: medical and well-being business, for the Distribution of medical and healthcare equipment and products.
54GF Score
Get the complete analysis for CCWYF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CCWYF has been successfully added to your 
